GDP

DRUG4 trials

Sponsors

Nanjing NingQi Medicine Science and Technology Co., Ltd., University of Karachi, Dipenkumar Modi, The Affiliated People's Hospital of Ningbo University

Conditions

Hematopoietic Stem Cell MobilizationLarge Cell Lymphoma, DiffuseNon-Hodgkin's LymphomaPeripheral T-cell LymphomasRefractory CancerRelapsed CancerTraumatic Stress, Post-Traumatic Growth

Phase 2

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Nanjing NingQi Medicine Science and Technology Co., Ltd.Peripheral T-cell Lymphomas

Start: 2014-12-31End: 2015-12-31Target: 60Updated: 2015-08-11

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

RecruitingNCT05852717

Dipenkumar ModiLarge Cell Lymphoma, Diffuse, Refractory Cancer, Relapsed Cancer

Start: 2023-10-31End: 2028-11-30Target: 32Updated: 2026-01-12

Phase 3

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

RecruitingNCT06520163

The Affiliated People's Hospital of Ningbo UniversityHematopoietic Stem Cell Mobilization, Non-Hodgkin's Lymphoma

Start: 2024-08-01End: 2026-08-31Target: 99Updated: 2025-12-04

Unknown Phase

To Observe the Psychophysiological Alterations in Traumatic Stress Subjects

CompletedNCT04217863

University of KarachiTraumatic Stress, Post-Traumatic Growth

Start: 2019-12-02End: 2021-08-10Updated: 2021-08-11

Related Papers

Etoposide-cytarabine-pegfilgrastim (EAP) and disease-specific chemotherapy regimens for hematopoietic stem cell mobilization in lymphoma: A randomized phase III trial

Blood2025-11-03

A Phase II Investigator-Initiated Trial of Epcoritamab with Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-Cell Lymphoma

Blood2024-11-051 citations